Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus (vol 10, 1151, 2019)
Barbara Soria-Juan,Natalia Escacena,Vivian Capilla-Gonzalez,Yolanda Aguilera,Lucia Llanos,Juan R. Tejedo,Francisco J. Bedoya,Veronica Juan, Antonio De la Cuesta,Rafael Ruiz-Salmeron,Enrique Andreu,Lukas Grochowicz,Felipe Prosper,Fermin Sanchez-Guijo,Francisco S. Lozano,Manuel Miralles,Lourdes Del Rio-Sola,Gregorio Castellanos,Jose M. Moraleda,Robert Sackstein,Mariano Garcia-Arranz,Damian Garcia-Olmo,Franz Martin,Abdelkrim Hmadcha,Bernat Soria FRONTIERS IN IMMUNOLOGY（2020）
摘要
[This corrects the article DOI: 10.3389/fimmu.2019.01151.].
更多查看译文
关键词
cellular medicaments,cell-based therapy,clinical trials,diabetes,critical limb ischemia,cost-effective
AI 理解论文
溯源树
样例
